论文部分内容阅读
目的:探讨大剂量阿糖胞苷治疗急性髓性白血病的临床疗效。方法:将我院近期收治的急性髓性白血病患者30例随机分为观察组15例和对照组15例,对照组给予常规化疗,观察组在治疗组的基础上给予大剂量阿糖胞苷治疗,比较两组患者的生存率。结果:观察组患者的生存率显著高于对照组,两组比较,差异具有显著性意义(P<0.05)。结论:大剂量阿糖胞苷治疗急性髓性白血病疗效满意,能显著延长患者的生存期,值得推广。
Objective: To investigate the clinical efficacy of high-dose cytarabine in the treatment of acute myeloid leukemia. Methods: Thirty patients with acute myeloid leukemia admitted to our hospital were randomly divided into observation group (15 cases) and control group (15 cases). The control group was given conventional chemotherapy. The observation group was given high dose of cytarabine on the basis of the treatment group , To compare the survival rate of two groups of patients. Results: The survival rate of the observation group was significantly higher than that of the control group. There was significant difference between the two groups (P <0.05). Conclusion: High dose of cytarabine is effective in treating acute myeloid leukemia, which can significantly prolong the survival of patients and is worth promoting.